But narrowing down the exact genes responsible proves to be complicated… While people of Mexican ancestry are nearly twice as likely to develop type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin. In an effort to understand …
Read More »Monthly Archives: January 2015
Glargine vs. Liraglutide in Poorly Controlled Type 2 Diabetes Treatment
Both medications lowered HbA1c and both groups of patients lost weight…. This randomized, multinational, open-label trial included subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5–12%. Subjects were assigned to 24 weeks of insulin glargine, titrated to target fasting plasma glucose of 4.0–5.5 mmol/L or liraglutide, escalated …
Read More »Linagliptin/Metformin Combination vs Linagliptin Monotherapy for Type 2 Diabetes
Earlier treatment for poorly controlled type 2 diabetes patients is advocated… Researchers from the University of Calgary, Alberta, Canada, evaluated glucose-lowering treatment strategies with linagliptin and metformin in people with newly diagnosed type 2 diabetes and marked hyperglycemia, a prevalent population for which few dedicated studies of oral antidiabetes drugs …
Read More »U.S. Obesity Rate Inches Up to 27.7% in 2014
This is up more than two percentage points since 2008 and is the highest obesity rate Gallup and Healthways have measured in seven years of tracking it. More Americans who were previously overweight have now moved into the obese category, while the percentage who are at normal weight has remained …
Read More »Abnormal Glucose and Variant Hemoglobin Status in Sub-Saharan Africans
In a group of 216 U.S.-based Africans, researchers analyzed the sensitivities of 1) FPG ≥5.6 mmol/L, 2) A1C ≥ 5.7% (39 mmol/mol), and 3) FPG combined with A1C (FPG ≥5.6 mmol/L and/or A1C ≥5.7% [39 mmol/mol]) for the detection of abnormal glucose tolerance in a population prone to sickle-cell anemia …
Read More »Only 6.8% of Privately Insured Adults Aged 18 to 64 Years Attended DSMT
Privately insured people with newly diagnosed diabetes are not participating in diabetes self-management education and training (DSMT), jeopardizing their ability to improve glycemic control and reduce the risk of complications and hospitalizations. Using the MarketScan Commercial Claims and Encounters database, researchers found that only 6.8% attended DSMT. Based on actual …
Read More »Dexcom G4 Platinum with SHARE Gets FDA Approval
The FDA has approved Dexcom’s G4 PLATINUM Continuous Glucose Monitoring System with Share. The Dexcom Share receiver uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient’s receiver and an app on the patient’s smartphone to transmit glucose information to apps on the mobile devices of …
Read More »Letter from the Editor, #766
When we see older men with diabetes in the office we often see the change in muscle mass and our first thought is to check testosterone levels. For many of these seniors the levels are acceptable and we just attribute the decline to their advancing age. But now a new …
Read More »Editor’s Note, DCMS #225
According to researchers from the CDC in Atlanta, medical spending attributable to diabetes per person doubled between 1987 and 2011. "The economic burden of the disease on patients and our health care system has increased substantially," Xiaohui Zhuo, PhD, of the agency’s Division of Diabetes Translation, National Center for Chronic …
Read More »Barbara E. Corkey, PhD, Introduction: The Unknown Causes of Diabetes and Obesity
Dr. Barbara E. Corkey introduces herself and explains a little about the work she and her team do in her lab, examining the effects of various substances, both nutritional and non-food substances, on the human cell…. More videos with Dr. Corkey: Introduction: The Unknown Causes of Diabetes and Obesity What …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.